Prognostic significance of antithrombin III, plasminogen and proactivator of plasminogen activity in viral hepatitis.
Antithrombin III/AT III/, plasminogen (Plg) and proactivator of plasminogen [PPlg] activity were studied in 663 patients with various liver diseases and 547 healthy subjects. Parallel analysis of AT III, Plg and PPlg gives a very valuable prognostic information concerning the forthcoming evolution of viral hepatitis [v.h] and acute liver failure. The prognosis of v.h. in the cases with normal Plg activity is independent from the AT III activity in 98% of the cases it is associated with clinical improvement. The combination with low Plg and elevated AT III activity suggested clinical improvement in 65-90% of the patients. Most critical is the combination between low Plg and low AT III activity. This combination suggests clinical aggravation and danger of hepatic coma. The existence of 4 patterns of AT III activity is shown: elevated, normal in physiological condition, normal in pathological condition and decreased activity.
Boyadjian
H P
HP
University School of Medicine, Department of Infectious Diseases and Epidemiology, Pleven, Medical Academy, Sofia.
D000990:Antithrombin III / Q000378:metabolism*; D004792:Enzyme Precursors / Q000378:metabolism*; D006501:Hepatic Encephalopathy / Q000097:blood; D006525:Hepatitis, Viral, Human / Q000097:blood*; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood; D010958:Plasminogen / Q000378:metabolism*; D010960:Plasminogen Activators / Q000378:metabolism*; D011379:Prognosis
D004792:Enzyme Precursors; C011074:plasminogen proactivator; D000990:Antithrombin III; D010958:Plasminogen; D010960:Plasminogen Activators